The outcome was encouraging: a healthy baby girl was delivered at 37 weeks with normal birth weight for gestational age
Infected individuals may also experience a low-grade fever, headache, body aches and fatigue
Development of Glucagon-Like Peptide 1 Receptor Agonists for the Management of Obesity Glucagon-like peptide 1 receptor agonists (GLP-1RAs), including liraglutide and semaglutide, were initially developed for the treatment of type 2 diabetes but were found to be effective not only in reducing blood glucose levels but body weight as well [18,19,20]
At the same time, the BBB prevents the penetration of various pathogens, metabolic products, and toxic compounds, preserving brain tissue from damage
This method is often used in clinical settings for acute treatments and detoxification protocols